Spectral Medical Inc T.EDT

Light at the end of the Tunnel

[TechOne]

So as the sites are added and pace of patience enrolement is picking up, I expect sooner or later 1 patient per site per month will happen..   So 2-4 months for some meaningful numbers is what I expect. as I have mentioned before.. 

I want to see a move to Nasdaq or NY but not at these levels because the management has last 3-4 years, every year around AGM time asked for share holder's approval for a reverse split of 1 for 10 or even as high as 1 for 20..  Needless to say, I don't like 1 for 20 reverse and certainly DO NOT want these guys to just list without serious numbers and Bexter's buy in at 90 patient interim results..  If you don't have very solid results to back it, reverse split is ALWAYS a losing proposition.. Do it right and if you can't, don't do it until share price is around at least couple of bucks..

Any ways, for now retail share holders IMHO have no clout for anything as long as they have Toray and another Instituion with big numbers of shares supporting the management..  I must say, CEO has been paid too handsomely for the results he has delivered...  Not really happy about it but for now holding my nose and keeping the shares.. 

FWIW

[mercedesman]

I hear ya... but... I am not in favour of adding 50-100m shares at low prices either.  The story is too good, the opportunity too immense, and the need too great.  Where is the media story? The reach out to the analyst community? The all important US investor ( 10X the population, 25X the appetite for these type of stocks)  Any listing upgrade must be accompanied by the

[oilandgasman]

good story? had i put this money someplace else i'd agree... This has not been a "good story" for any investor involved.

[jonnieboy]

Positive. Often, companies that use reverse stock splits are in distress. But if a company times the reverse stock split along with significant changes that improve operations, projected earnings and other information important to investors, the higher price may stick and could rise further. In this instance, the reverse stock split was a success for both the company and its shareholders

[MMABStrader]

CytoSorbents (CTSO) did a 1:25 reverse split several years ago and the share price could not be sustained and today it's share price is $2.89. In December it was down to $1.03. I agree... there needs to be some sustainable good news in order to justify a reverse split.

[BayStreetWild]

It destroys the early investors most of the time. Pays the last guys in.

[mercedesman]

You just made my case.  CTso trades in the US , no Trial, double the MC  There is a demand side problem with the supply/ demand equation  OTCQX requires >$1 To argue against  RS ( to setup US presence) is to argue for (1) heavier go-forward dilution - and relinquishing future profits to a bunch of late-comers, and those with far less skin in the game ( eg option

[hmmmmmmmm]

So that would have CTSO floating in the 11- 4 cent pre split share price..  Hard to see their investors being excitied about that.

[mercedesman]

Huh?? show your math and how that's relevant to the fact they are worth ( as a Company) twice as much as Spectral ...despite having no prospect of an FDA approval for the US  Could it be ....their exposure to US investors as a possible future blood filtration treatment for Sepsis?  Based on proximity to approval, Spectral should have a value that is 2X not 1/2 X of CTSO

[Stocktree]

Another one of MM's misleading posts. The issue is not the worth of CTSO compared to that of EDT. The issue is what happened to the worth of CTSO shares after the reverse split.

[mercedesman]

Another one of treeboy's misleading posts. He just parrots the off-repeated standard "reverse splits never work out" without analyzing the facts of the situation. The issue is exactly the worth of CTSO compared to that of EDT.... ....which is highly likely to be a function of where it trades (ie. mostly the US for CTSO) and promotional efforts.  How else can a Company with

[BayStreetWild]

I'm no expert but I would say the value reflects the way the company runs. I alongside others am not happy with executive compensation and the way it's handled. Others are not happy with the pace of the trial. Many other reasons have been mentioned. That's why it's trading at a discount.

[BayStreetWild]

And I would think having a reverse split hanging over peoples heads for 5 years is turning off a lot of investors because although you might not recognize it as such... it is a huge risk.

[BayStreetWild]

Mass departures of staff... Not to mention employee reviews on glassdoor don't leave a favourable review of  management as many talk about executive greed. Then there's the whole issue of hiring staff as if to run a dialco trial and as soon as that looks good on paper and they run a financing they fire said staff with severance and announce they're divesting..... I mean aside from

[Stocktree]

You are just an output, never an input. My tweet was the shortest than can be. Never have I repeated any concept about reverse splits. I just pointed out that are using false arguments to analyse a situation. Comparing the worth of 2 companies at a certain date is not useful to determine whether the company that performed a RS was right to do so. What you should do is compare the worth of the RS

[mercedesman]

Let me boil it down for you. A RS for the sake of a RS would be a bad idea...as it as for many other companies that have tried it. A reverse split as a requirement to uplist on a much better exchange (more liquidity, way more investors), combined with much better IR/PR (for a change) would likely be very rewarding to SH'ers. Doing nothing - invites more of the same. Buying today

[BayStreetWild]

This is all you have as your counter argument? Jeez... the best you have is... a reverse split is good????

[oilandgasman]

Still aa long tunnel..years, not months till the FDA works through this, we've been here before nothing moves quickly.. sorry to burst the fake bubble pumpers